BlueCrest Capital Management’s Celldex Therapeutics CLDX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q4 | – | Sell |
-14,213
| Closed | -$96K | – | 930 |
|
|
2018
Q3 | $96K | Buy |
14,213
+1,325
| +10% | +$8.95K | ﹤0.01% | 1372 |
|
|
2018
Q2 | $97K | Buy |
12,888
+5,265
| +69% | +$39.6K | ﹤0.01% | 1362 |
|
|
2018
Q1 | $266K | Buy |
+7,623
| New | +$266K | 0.01% | 1107 |
|
|
2017
Q4 | – | Sell |
-6,029
| Closed | -$259K | – | 849 |
|
|
2017
Q3 | $259K | Buy |
6,029
+1,778
| +42% | +$76.4K | 0.01% | 653 |
|
|
2017
Q2 | $158K | Buy |
+4,251
| New | +$158K | 0.01% | 758 |
|
|
2015
Q4 | – | Sell |
-1,879
| Closed | -$297K | – | 956 |
|
|
2015
Q3 | $297K | Buy |
+1,879
| New | +$297K | 0.01% | 624 |
|